MRV Engenharia e Participações (MRVE3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Nov, 2025Executive summary
Operational and financial indicators improved quarter on quarter, with net revenue reaching R$2.18 billion in 1Q25, up 17.5% year-over-year, and launches growing 81.2% year-over-year to R$2.89 billion.
Despite run-offs from Resia and a portfolio sale, management remains confident in meeting guidance, with strong positioning in Brazil's low-income housing market.
Resia deleveraging initiated with asset sales, impacting short-term earnings but expected to drive strong future cash generation; US operation posted a net loss of US$52.3 million due to asset sales and impairments.
Preliminary, non-audited results show stable pre-sales, but temporary transfer delays and new payment methods impacted cash generation.
Financial highlights
Net revenue increased by 17.5% year-over-year, with 9,454 units built in Q1 2025 and launches reaching R$2,888 million, up 81.2% year-over-year.
Gross margin reached 29.6% after interest, up 3.7 p.p. year-over-year.
EBITDA improved 43% year-over-year and 22% sequentially, but adjusted net income attributable to shareholders was R$26 million, down 67% from 4Q24.
Cash generation was negative at R$50.8 million, mainly due to delayed transfers and changes in Caixa payment modalities.
Debt to EBITDA ratio improved to 1.27x from 1.84x a year ago.
Outlook and guidance
Confident in meeting 2025 guidance for income, sales price, and margin, with cash generation expected to improve each quarter.
Backlog of untransferred units is being addressed in 2Q25 as regional program issues are resolved.
Resia asset sales planned to generate $500 million to $800 million in cash by end of 2026, supporting deleveraging.
Guidance incorporates delays from changes in Caixa's accounting criteria and regional program adjustments.
Latest events from MRV Engenharia e Participações
- Margin expansion, operational excellence, and asset-light focus drive improved results.MRVE3
Investor Day 202610 Mar 2026 - Strong profitability growth and margin expansion, with continued US asset divestment.MRVE3
Q4 202510 Mar 2026 - Record pre-sales and margin recovery drive robust 2Q24 results across all segments.MRVE3
Q2 20242 Feb 2026 - Record pre-sales and cash generation drive robust Q3 2024 performance and outlook.MRVE3
Q3 202414 Jan 2026 - Record sales, margin gains, and cash generation in 2024 set up strong 2025 growth and deleveraging.MRVE3
Q4 202417 Dec 2025 - Operational simplification, capital-light focus, and tech-driven efficiency set stage for record growth.MRVE3
Investor Day 202529 Nov 2025 - Record revenue and margin growth in Brazil offset by US impairments and high leverage.MRVE3
Q2 202523 Nov 2025 - Net income rose to R$204 million in 3Q25, with higher margins and improved leverage.MRVE3
Q3 202517 Nov 2025 - Operational turnaround, efficiency gains, and strategic reset drive improved performance.MRVE3
Corporate Presentation13 Nov 2025